Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)
MDGL surges on acquisition rumors and positive trial data, but profit-taking causes a slight dip. Analysts remain optimistic with target raises.
About Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a biopharmaceutical company focused on therapeutics for non-alcoholic steatohepatitis (NASH).
Madrigal Pharmaceuticals, Inc. Common Stock uses the ticker $MDGL for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) social dominance is up 1088.1% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) creators is up 55.46% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) engagements is up 151.42% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) mentions is up 55.82% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) posts created is up 90.48% from the previous week.
Price: $464.70
Price 24-Hour Time-Series Raw Data
The stock price has experienced a slight decline due to profit-taking after a surge from acquisition rumors and positive clinical trial results, with analyst target raises not fully offsetting selling pressure.
24-Hour: -2.02% 7-Day: -4.82% 30-Day: -7.37%
1-Year High: $602.80 on 2025-12-22
1-Year Low: $267.30 on 2025-05-24
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently AltRank #387 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +71
[--] Months: [---] +335
[--] Year: [---] [----]
1-Year High: [-----] on 2025-04-19
1-Year Low: [--] on 2025-05-03
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-11-04
1-Year Low: [--] on 2026-02-05
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +151%
[--] Month: [-------] -51%
[--] Months: [---------] -32%
[--] Year: [---------] +6.40%
1-Year High: [-------] on 2025-08-18
1-Year Low: [-----] on 2026-02-08
Engagements by network (24h): News: [--] Reddit: [--] X: [-----] YouTube: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +56%
[--] Month: [---] +10%
[--] Months: [-----] -35%
[--] Year: [------] +36%
1-Year High: [-----] on 2025-07-17
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): News: [--] Reddit: [--] X: [---] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) in the last [--] hours which is down 17% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +55%
[--] Month: [---] +27%
[--] Months: [-----] -46%
[--] Year: [-----] +68%
1-Year High: [---] on 2025-07-17
1-Year Low: [--] on 2026-02-12
The most influential creators that mention Madrigal Pharmaceuticals, Inc. Common Stock in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BioStocks | [--] | [------] | [--] | [-----] |
| @RyshabTalks | [--] | [-----] | [--] | [---] |
| @MACROVET888 | [--] | [-----] | [--] | [---] |
| @Pharmdca | [--] | [-------] | [--] | [---] |
| @SeanValenc89161 | [--] | [---] | [--] | [---] |
| @Jamce1182025 | [--] | [--] | [--] | [--] |
| @WallStSai | [--] | [-----] | [--] | [--] |
| @OptionsAlertsAi | [--] | [---] | [--] | [--] |
| @SnackBioTech | [--] | [-----] | [--] | [--] |
| @JoseRestonVA | [--] | [-----] | [--] | [--] |
Sentiment: 60%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 60%
Daily Average: 79%
[--] Week: 38% -62%
[--] Month: 60% -11%
[--] Months: 60% -29%
[--] Year: 60% -16%
1-Year High: 98% on 2025-07-17
1-Year Low: 38% on 2025-12-06
Most Supportive Themes:
- Acquisition Target: (45%) Madrigal Pharmaceuticals is viewed as a potential acquisition by larger pharmaceutical companies.
- Positive Clinical Trial Results: (30%) Recent positive trial results for Rezdiffra and Madrigal's market leadership in MASH are highlighted.
- Undervalued Stock: (20%) Many investors believe MDGL is undervalued, presenting a strong buying opportunity.
Most Critical Themes:
- Profit-Taking and Market Manipulation: (5%) The recent price decline is attributed to profit-taking and potential market manipulation.
Social Dominance: 0.012%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.012%
Daily Average: 0.026%
[--] Week: 0.05% +0.046%
[--] Month: 0.028% +0.016%
[--] Months: 0.028% -0.033%
[--] Year: 0.028% +0.0037%
1-Year High: 0.145% on 2025-07-17
1-Year Low: 0.0046% on 2026-02-12
Market Dominance: 0.012%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.012%
Daily Average: 0%
1-Year High: 0.265% on 2025-03-25
1-Year Low: 0.00827% on 2025-06-25
Market Cap: $10,554,223,988
Market Cap 24-Hour Time-Series Raw Data
Current Value: $10,554,223,988
Daily Average: $9,030,434,694
[--] Week: $10,349,366,980 -6.70%
[--] Month: $10,554,223,988 -7.40%
[--] Months: $10,554,223,988 +21%
[--] Year: $10,554,223,988 +44%
1-Year High: $13,691,125,319 on 2025-12-22
1-Year Low: $5,940,710,132 on 2025-05-23
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing